SCREEN for Type 1 Diabetes Act of 2026
- Sponsor
- Sen. Shaheen, Jeanne [D-NH]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- May 20, 2026
Bottom line
This bill creates a federally funded national public awareness campaign and grant program to improve early detection, screening, and management of type 1 diabetes, with a focus on equitable access to information and resources.
What it actually does
This bill amends the Public Health Service Act to establish a national, evidence-based public awareness campaign led by the Director of the Centers for Disease Control and Prevention (CDC). The campaign aims to increase knowledge among healthcare providers and the public regarding type 1 diabetes detection, screening, and management. It mandates the development of written materials, public service announcements, and targeted outreach to communities most impacted, while authorizing $5,000,000 annually for fiscal years 2027 through 2031 for its implementation.
Proponents argue
Supporters argue that early detection of type 1 diabetes is critical for preventing severe, life-threatening complications like diabetic ketoacidosis and improving long-term health outcomes. They contend that a national awareness campaign, especially one focused on culturally and linguistically competent resources for high-incidence communities, is a cost-effective investment that will save lives and reduce healthcare burdens by promoting timely diagnosis and appropriate management.
Opponents contend
Critics might argue that while the intent is laudable, the effectiveness of broad public awareness campaigns can be difficult to measure and that resources could potentially be more efficiently allocated to direct research, treatment access, or existing public health infrastructure. Concerns could also be raised about the administrative overhead of managing extensive consultations and grant programs, or the potential for duplication with ongoing private or federal initiatives.
The bill is very concise and clearly written, making it highly accessible for a reader to understand its provisions and implications quickly.
Section 2(a), amending Section 317H(c) of the Public Health Service Act
Establishment of National Type 1 Diabetes Public Awareness Campaign
This provision directs the Secretary of Health and Human Services, through the CDC Director, to carry out an evidence-based national campaign. The campaign's goal is to increase awareness and knowledge among both healthcare providers and the general public regarding the detection, screening, and management of type 1 diabetes. It requires the campaign to maintain publicly accessible written materials and develop public service announcements across various media, including social media, television, and radio.
Supporters argue
Supporters argue that this campaign is vital for improving public health by promoting early diagnosis of type 1 diabetes, which can prevent severe complications like diabetic ketoacidosis and reduce long-term healthcare costs. They emphasize that a national, coordinated effort is necessary to reach a broad audience and ensure consistent, evidence-based messaging.
Critics contend
No specific opposition is typically raised against public health awareness campaigns of this nature, as they are generally viewed as beneficial. Potential concerns might focus on the efficiency of federal spending or the specific messaging, rather than the core intent of increasing awareness.
Tradeoffs
The primary tension involves balancing the need for broad national messaging with the imperative to develop culturally and linguistically competent resources tailored for specific communities, ensuring effective reach and impact across diverse populations within the allocated budget.
Section 2(a), amending Section 317H(c)(5)(B) and (C)
Grants for Campaign Implementation and Increased Screening
This provision outlines the mechanisms for carrying out the national campaign. It directs the Secretary to implement the campaign through grants or cooperative agreements with one or more private, nonprofit entities experienced in similar public health campaigns. Additionally, it authorizes grants to State, local, and Tribal public health departments. These grants are intended to support engagement with communities, local educational agencies, and healthcare providers to develop and deliver effective strategies for increasing type 1 diabetes screening and to disseminate information on local screening access.
Section 2(a), amending Section 317H(c)(8)
Authorization of Appropriations
This provision authorizes the appropriation of $5,000,000 for each of fiscal years 2027 through 2031 to fund the type 1 diabetes public awareness campaign. These funds are designated to remain available until expended, allowing for flexibility in their use over time.
The national campaign must include the development of culturally and linguistically competent resources tailored to communities with the largest significant increases in type 1 diabetes incidence, and must include message testing to identify effective messages.
Section 2(a), new subsection (c)(5)(A)(ii) and (v)
Why it matters:This is standard legislative practice for detailing operational specifics within a broader mandate, rather than an attempt to obscure the provision.
Case for: Proponents argue that these requirements are essential for the campaign's effectiveness and equity, ensuring that information reaches and resonates with diverse populations who may face unique barriers to healthcare information and access. Message testing ensures the campaign's communications are impactful.
Case against: No specific opposition is typically raised against these provisions, as they represent public health best practices. Some might argue that such specific mandates could add administrative complexity or cost, but generally, they are seen as beneficial for campaign efficacy.
Estimated impact: These requirements enhance the overall effectiveness and equitable reach of the $25 million national campaign, potentially leading to more significant and widespread improvements in health literacy and early detection rates.